198 related articles for article (PubMed ID: 29579624)
21. Sumo Modification of Ion Channels.
Benson M; Iñiguez-Lluhí JA; Martens J
Adv Exp Med Biol; 2017; 963():127-141. PubMed ID: 28197910
[TBL] [Abstract][Full Text] [Related]
22. From foe to friend: using animal toxins to investigate ion channel function.
Kalia J; Milescu M; Salvatierra J; Wagner J; Klint JK; King GF; Olivera BM; Bosmans F
J Mol Biol; 2015 Jan; 427(1):158-175. PubMed ID: 25088688
[TBL] [Abstract][Full Text] [Related]
23. An assessment of the present and future roles of non-ligand gated ion channel modulators as CNS therapeutics.
Gribkoff VK; Starrett JE
Expert Opin Pharmacother; 1999 Nov; 1(1):61-70. PubMed ID: 11249565
[TBL] [Abstract][Full Text] [Related]
24. Immunopharmacology--antibodies for specific modulation of proteins involved in neuronal function.
Dallas M; Deuchars SA; Deuchars J
J Neurosci Methods; 2005 Aug; 146(2):133-48. PubMed ID: 16045997
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological modulation of ion channels and transporters.
Ravens U; Wettwer E; Hála O
Cell Calcium; 2004 Jun; 35(6):575-82. PubMed ID: 15110147
[TBL] [Abstract][Full Text] [Related]
26. Voltage-gated ion channels.
Nau C
Handb Exp Pharmacol; 2008; (182):85-92. PubMed ID: 18175087
[TBL] [Abstract][Full Text] [Related]
27. Novel perspectives in cancer therapy: Targeting ion channels.
Arcangeli A; Becchetti A
Drug Resist Updat; 2015; 21-22():11-9. PubMed ID: 26183291
[TBL] [Abstract][Full Text] [Related]
28. Ion channels as therapeutic antibody targets.
Hutchings CJ; Colussi P; Clark TG
MAbs; 2019; 11(2):265-296. PubMed ID: 30526315
[TBL] [Abstract][Full Text] [Related]
29. Discovery of functional monoclonal antibodies targeting G-protein-coupled receptors and ion channels.
Wilkinson TC
Biochem Soc Trans; 2016 Jun; 44(3):831-7. PubMed ID: 27284048
[TBL] [Abstract][Full Text] [Related]
30. Fast kinetic analysis of ligand-gated ion channels.
Breitinger HG
Neuroscientist; 2001 Apr; 7(2):95-103. PubMed ID: 11496930
[TBL] [Abstract][Full Text] [Related]
31. Ion channels: gate expectations.
Garcia ML
Nature; 2004 Jul; 430(6996):153-5. PubMed ID: 15241399
[No Abstract] [Full Text] [Related]
32. Voltage-dependent gating in a "voltage sensor-less" ion channel.
Kurata HT; Rapedius M; Kleinman MJ; Baukrowitz T; Nichols CG
PLoS Biol; 2010 Feb; 8(2):e1000315. PubMed ID: 20208975
[TBL] [Abstract][Full Text] [Related]
33. Toxins as tools: Fingerprinting neuronal pharmacology.
Israel MR; Morgan M; Tay B; Deuis JR
Neurosci Lett; 2018 Jul; 679():4-14. PubMed ID: 29425731
[TBL] [Abstract][Full Text] [Related]
34. Transforming nanobodies into high-precision tools for protein function analysis.
Gettemans J; De Dobbelaer B
Am J Physiol Cell Physiol; 2021 Feb; 320(2):C195-C215. PubMed ID: 33264078
[TBL] [Abstract][Full Text] [Related]
35. Introduction: Applying Chemical Biology to Ion Channels.
Pless SA; Ahern CA
Adv Exp Med Biol; 2015; 869():1-4. PubMed ID: 26381937
[TBL] [Abstract][Full Text] [Related]
36. Molecular biology and biophysical properties of ion channel gating pores.
Moreau A; Gosselin-Badaroudine P; Chahine M
Q Rev Biophys; 2014 Nov; 47(4):364-88. PubMed ID: 25382261
[TBL] [Abstract][Full Text] [Related]
37. The development of nanobodies for therapeutic applications.
Van Bockstaele F; Holz JB; Revets H
Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
[TBL] [Abstract][Full Text] [Related]
38. Engineering light-gated ion channels.
Banghart MR; Volgraf M; Trauner D
Biochemistry; 2006 Dec; 45(51):15129-41. PubMed ID: 17176035
[TBL] [Abstract][Full Text] [Related]
39. Nanobodies as probes to investigate purinergic signaling.
Eggers M; Rühl F; Haag F; Koch-Nolte F
Biochem Pharmacol; 2021 May; 187():114394. PubMed ID: 33388283
[TBL] [Abstract][Full Text] [Related]
40. Antibodies and venom peptides: new modalities for ion channels.
Wulff H; Christophersen P; Colussi P; Chandy KG; Yarov-Yarovoy V
Nat Rev Drug Discov; 2019 May; 18(5):339-357. PubMed ID: 30728472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
